Literature DB >> 28669491

[Community prioritization in Barcelona Salut als Barris program].

Esther Sánchez-Ledesma1, Anna Pérez2, Noelia Vázquez3, Irene García-Subirats4, Ana Fernández5, Ana M Novoa6, Ferran Daban7.   

Abstract

Prioritizing corresponds to the process of selecting and managing health needs identified after diagnosing the community's health needs and assets. Recently, the health needs assessment has been reinforced with the community perspective, providing multiple benefits: it sensitizes and empowers the community about their health, encourages mutual support among its members and promotes their importance by making them responsible for the process of improving their own reality. The objective of this paper is to describe the prioritization of Barcelona Salut als Barris, a community health strategy led by the Barcelona Public Health Agency to promote equity in health in the most disadvantaged neighborhoods of the city.
Copyright © 2017 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Keywords:  Acción comunitaria; Citizen participation; Community action; Desigualdades en salud; Health inequalities; Health needs; Necesidades en salud; Participación ciudadana; Prioritization; Priorización

Mesh:

Year:  2017        PMID: 28669491     DOI: 10.1016/j.gaceta.2017.04.005

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  2 in total

Review 1.  [Prioritization of health resources in contexts of scarcity. SESPAS Report 2022].

Authors:  Javier Ruiz-Hornillos; Marta Albert; Diego Real de Asua; María Herrera Abián; Íñigo de Miguel Beriain; Encarna Guillén-Navarro
Journal:  Gac Sanit       Date:  2022       Impact factor: 2.479

2.  Promoting Health in a Rural Community in the Basque Country by Leveraging Health Assets Identified through a Community Health Diagnosis.

Authors:  Maria Jose Alberdi-Erice; Esperanza Rayón-Valpuesta; Homero Martinez
Journal:  Int J Environ Res Public Health       Date:  2022-01-06       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.